
The growing demand for expanding production lined requires an expansion of CSL's manufacturing capacity. To support this growth, immunoglobulin (Ig) production activities—from plasma thawing through sterile filling—will be incorporated into the new Building under construction at the CSL Kankakee (KAN) site to accommodate Ig production. The new fill-finish facility is part of the Ig manufacturing expansion, known as Module (M) 7/8.
This role will provide Quality oversight for change control activities associated with the M 7/8 Site Expansion Project at the CSL Behring Kankakee site.
The Associate Director, Quality Control (QC) will provide strategic and operational leadership for Quality Control activities supporting the M7/M8 Immunoglobulin (Ig) Expansion Project. This role is accountable for building and leading a high-performing QC organization that ensures successful project execution, regulatory compliance, operational readiness, method lifecycle management, laboratory qualification, and commercialization support for expanded manufacturing capacity.
The individual will serve as a key member of the Project Quality leadership team and cross-functional project governance structure. Forming key partnerships with the Site QC and Operational Quality team to ensure delivery of the robust and complaint operational QC laboratory fit to the expansion.
Other partnerships within Manufacturing, QC Technical Services , Engineering, Technical Operations, Validation, Global Quality, Regulatory Affairs, and Supply Chain to deliver project milestones while maintaining compliance with cGMP, regulatory requirements, and company quality standards.
Reports To: Senior Director, Project Quality
Direct Reports: QC Analysts, QC Sample Management Associate, QCAT Associates
The expected base salary range for this position at hiring is $154,000- $193,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position at the listed location as of the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
